We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 02 FEBRUARY 2016
Pfizer v. Lee: A Patent Term Adjustment Double Standard?
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
In Pfizer v. Lee (No. 2015-1265, January 22, 2016), the Federal Circuit upheld the USPTO's determination that the toll period for A-type patent term adjustment delay stops upon the mailing of a deficient USPTO paper.
United StatesIntellectual Property









